Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of cryopreservation technology created to facilitate preservation of eukaryotic cells. The company's cryopreservation technology allows obtaining optimal survival yields while keeping unchanged the biological properties for all cell types used in research, enabling researchers to increase the success rate of biological research and cell therapy while promoting the biological safety of the products.
You’re viewing a free company profile from the PitchBook Platform. To explore VitriCell’s full profile, request a free trial.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Angel (individual) | 23-Jan-2018 | $1.22M | 00000 | Completed | Startup | |
1. Capitalization | 01-Jun-2017 | 00000 | 00000 | Completed | Startup |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
---|---|---|---|---|---|---|
Be Angels | Angel Group | Minority | 000 0000 | 000000 0 | ||
Gesval | Lender/Debt Provider | Minority | 000 0000 | 000000 0 | ||
Jean-Pierre Delwart | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
University of Liege | Corporation | Minority | 000 0000 | 000000 0 | ||
WBC | Accelerator/Incubator | 000 0000 | 000000 0 |
Name | Representing | Role | Since | Contact Info |
---|---|---|---|---|
Annick Houbrechts | VitriCell | Board Member | 000 0000 | |
Eric Halioua | VitriCell | Chairman | 000 0000 | |
Françoise Leblanc | VitriCell | Board Member | 000 0000 | |
Joseph de Gheldere | VitriCell | Board Member | 000 0000 | |
Marc-Henri Decrop | Self | Board Member | 000 0000 |